Therapeutic Area Strategy Head, CRM

About this role

Responsibilities

• Provides external perspective and identifies opportunities:
• Builds and maintains in-depth knowledge of the TA (early pipeline to commercial); including disease models; responsible for ongoing assessment of peer companies with heavy exposure in the TA.
• Educates, updates and provides external views to all internal stakeholders.  Provides insight within key portfolio governance processes (diligence and external landscape mapping with BD&L and M&A)
• Supports identification of growth accretive opportunities, indications, disease spaces and rejection of low value opportunities/projects
• Supports Group Investor Relations and the CEO Office with dissemination of key strategic insights
• Ongoing collection and synthesis of scientific and commercial insights for the TA
• Owns TA portfolio strategy and prioritization:
• Leads the process of creating, maintaining and updating enterprise-wide TA portfolio strategy, including disease area and molecule selection to drive mid- and long-term growth in collaboration with RDC
• Identifies potential pipeline gaps, makes recommendations to address
• Works closely with key stakeholders in the Therapeutic Area Leadership (TAL) team to facilitate portfolio decision making, prioritization and trade-offs
• Internal and External Commercial and Pipeline Modelling:
• Oversees assessments of programs fit to current portfolio strategy and facilitates central review for assets inside and outside current priorities (e.g., at Innovation Management Board (IMB))
• Provides consolidated commercial and development inputs to support business cases for internal and external assets and programs
• Provides outside-in independent view of internal assumptions around core pipeline
• Leads the development of assessment of external opportunities (e.g., forecast assumptions, business cases)
• Others:
• Coaches, attracts, develops, and retains top talents; partners with P&O leadership to develop people strategy (e.g. organization development, performance, career development).
• Plans, allocates, and manages TA strategy financial budget by anticipating expenditures, accurately forecasting resource needs/costs and properly accounting for expenses to meet requirements and achieve fiscal responsibility

Requirements

• Advanced degree or equivalent experience in life science/healthcare required, Cardiologist training highly desirable
• Demonstrated cross
• ‑
• functional global leadership experience is essential.
• Minimum 10 years of pharmaceutical/biotech experience gained in banking, consulting, or biopharma, with exposure to drug development and ideally commercialization required. Proven ability to operate effectively in a highly matrixed, fast paced environment.
• Candidates with significant senior leadership experience — including Biotech CEOs and executives from investment banking or other Wall Street institutions are strongly preferred
• Ability to comfortably engage with the C-suite and mid-career associates to influence and challenge with excellent interpersonal and leadership skills
• Strong financial and business acumen with strong understanding of biopharma landscape; companies, assets and early technologies
• Strong strategic vision, superior leadership, excellent communication, consensus building, and well-developed influencing and negotiation skills
• Excellent conflict resolution skills to facilitate agreement and buy-in at the senior-most levels
• Experience leading and managing a team with a variety of insights from science to commercial and proven coaching and mentoring experience
• Commitment to Diversity and Inclusion:
• Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.